Lynsey M. Whilding

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

Lynsey M. Whilding, Leena Halim, Benjamin Draper et al. · Cancers · 2019 · 188 citations · Full text

Several Solid Malignancies, Immunology, Immune Regulation +23

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy et al. · Frontiers in Immunology · 2019 · 181 citations · Full text

T Cell Therapy, Breast Oncology, Immunology +22

Ovarian Cancer Immunotherapy Using PD‐L1 siRNA Targeted Delivery from Folic Acid‐Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing

Pei Y. Teo, Chuan Yang, Lynsey M. Whilding et al. · Advanced Healthcare Materials · 2015 · 170 citations

Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?

Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie et al. · The Journal of Immunology · 2013 · 128 citations

Cell Therapy, Therapeutic Opportunity, Adaptive Immune System +21

Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer

Christian J. Maine, Nor Haslinda Abd Aziz, Jayanta Chatterjee et al. · Cancer Immunology Immunotherapy · 2013 · 120 citations · Full text

Cancer Immunosurveillance, Medicine, Apoptosis +10